141 related articles for article (PubMed ID: 2448025)
21. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
[TBL] [Abstract][Full Text] [Related]
22. The value of immunohistochemistry in medullary thyroid carcinoma: a systematic study of 30 cases.
Krisch K; Krisch I; Horvat G; Neuhold N; Ulrich W
Histopathology; 1985 Oct; 9(10):1077-89. PubMed ID: 2417931
[TBL] [Abstract][Full Text] [Related]
23. Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity?
Holm R; Sobrinho-Simões M; Nesland JM; Sambade C; Johannessen JV
Lab Invest; 1987 Sep; 57(3):258-68. PubMed ID: 3626517
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid.
Schmid KW; Kirchmair R; Ladurner D; Fischer-Colbrie R; Böcker W
Histopathology; 1992 Sep; 21(3):225-32. PubMed ID: 1356907
[TBL] [Abstract][Full Text] [Related]
25. Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
Ito Y; Miyauchi A; Kihara M; Higashiiyama T; Fukushima M; Miya A
World J Surg; 2018 Dec; 42(12):3954-3966. PubMed ID: 30051240
[TBL] [Abstract][Full Text] [Related]
26. [Histopathological and immunohistochemical studies on medullary thyroid carcinoma].
Jiang C; Tan Y; Li E
Zhonghua Bing Li Xue Za Zhi; 1996 Dec; 25(6):332-5. PubMed ID: 9388857
[TBL] [Abstract][Full Text] [Related]
27. [Surgical treatment and prognosis analysis on medullary thyroid carcinoma].
Zhang ZX; Li ZJ; Tang PZ; Xu ZG; Zhang ZM; An CM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 46(3):209-13. PubMed ID: 21575412
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonographic Features of Medullary Thyroid Carcinoma: Do they Correlate with Pre and PostOperative Calcitonin Levels?
Cho KE; Gweon HM; Park AY; Yoo MR; Kim J; Youk JH; Park YM; Son EJ
Asian Pac J Cancer Prev; 2016; 17(7):3357-62. PubMed ID: 27509975
[TBL] [Abstract][Full Text] [Related]
29. Chromogranin A immunoreactivity compared with argyrophilia, calcitonin immunoreactivity, and amyloid as tumour markers in the histopathological diagnosis of medullary (C-cell) thyroid carcinoma.
Harach HR; Wilander E; Grimelius L; Bergholm U; Westermark P; Falkmer S
Pathol Res Pract; 1992 Feb; 188(1-2):123-30. PubMed ID: 1594480
[TBL] [Abstract][Full Text] [Related]
30. Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ishizaki T
Mod Pathol; 1996 Jun; 9(6):631-5. PubMed ID: 8782199
[TBL] [Abstract][Full Text] [Related]
31. Clinical and pathological analysis of 19 cases of medullary thyroid carcinoma without an increase in calcitonin.
Zhou Q; Yue S; Cheng Y; Jin J; Xu H
Exp Toxicol Pathol; 2017 Oct; 69(8):575-579. PubMed ID: 28552629
[TBL] [Abstract][Full Text] [Related]
32. Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature.
Uribe M; Fenoglio-Preiser CM; Grimes M; Feind C
Am J Surg Pathol; 1985 Aug; 9(8):577-94. PubMed ID: 2418697
[TBL] [Abstract][Full Text] [Related]
33. A study of FoxA1 expression in thyroid tumors.
Nonaka D
Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract][Full Text] [Related]
35. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
37. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
Papapetrou PD; Polymeris A
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
[TBL] [Abstract][Full Text] [Related]
38. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
[TBL] [Abstract][Full Text] [Related]
39. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
[TBL] [Abstract][Full Text] [Related]
40. SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival.
de Vries LH; Lodewijk L; Willems SM; Dreijerink KMA; de Keizer B; van Diest PJ; Schepers A; Bonenkamp HJ; van Engen-van Grunsven IACH; Kruijff S; van Hemel BM; Links TP; Nieveen van Dijkum EJM; van Eeden S; Valk GD; Borel Rinkes IHM; Vriens MR
Endocrine; 2018 Dec; 62(3):639-647. PubMed ID: 30128959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
